HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

Conditions: HCC - Hepatocellular Carcinoma Interventions: Drug: PD-L1 inhibitor: Adebrelimab Injection ；Regorafenib Tablets Sponsors: Yehua Shen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials